AllianceBernstein’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$184K Hold
187,700
﹤0.01% 3066
2025
Q4
$184K Hold
187,700
﹤0.01% 3083
2025
Q3
$237K Hold
187,700
﹤0.01% 3025
2025
Q2
$210K Buy
187,700
+41,120
+28% +$47.8K ﹤0.01% 3040
2025
Q1
$116K Hold
146,580
﹤0.01% 3045
2024
Q4
$242K Hold
146,580
﹤0.01% 2975
2024
Q3
$513K Hold
146,580
﹤0.01% 2651
2024
Q2
$481K Buy
146,580
+46,200
+46% +$202K ﹤0.01% 2693
2024
Q1
$737K Sell
100,380
-60,380
-38% -$374K ﹤0.01% 2417
2023
Q4
$601K Sell
160,760
-800
-0.5% -$1.89K ﹤0.01% 2519
2023
Q3
$343K Buy
161,560
+34,430
+27% +$114K ﹤0.01% 2752
2023
Q2
$605K Buy
127,130
+25,330
+25% +$140K ﹤0.01% 2538
2023
Q1
$580K Sell
101,800
-200,000
-66% -$1.21M ﹤0.01% 2492
2022
Q4
$3.05M Buy
301,800
+200,000
+196% +$3.76M ﹤0.01% 1664
2022
Q3
$2.28M Sell
101,800
-39,990
-28% -$1.16M ﹤0.01% 1805
2022
Q2
$3.51M Sell
141,790
-157
-0.1% -$4.33K ﹤0.01% 1622
2022
Q1
$5.5M Buy
141,947
+357
+0.3% +$13.8K ﹤0.01% 1540
2021
Q4
$8.28M Hold
141,590
﹤0.01% 1349
2021
Q3
$8.39M Sell
141,590
-600
-0.4% -$47.1K ﹤0.01% 1331
2021
Q2
$12.3M Buy
142,190
+13,020
+10% +$1.05M 0.01% 1129
2021
Q1
$10.7M Buy
129,170
+29,970
+30% +$2.87M ﹤0.01% 1170
2020
Q4
$9.02M Buy
99,200
+7,800
+9% +$484K ﹤0.01% 1179
2020
Q3
$3.65M Buy
91,400
+5,600
+7% +$196K ﹤0.01% 1508
2020
Q2
$2.94M Buy
85,800
+5,100
+6% +$152K ﹤0.01% 1627
2020
Q1
$1.79M Buy
80,700
+9,400
+13% +$238K ﹤0.01% 1726
2019
Q4
$1.4M Buy
71,300
+2,800
+4% +$44.5K ﹤0.01% 2130
2019
Q3
$1.06M Hold
68,500
﹤0.01% 2225
2019
Q2
$1.39M Buy
68,500
+8,700
+15% +$157K ﹤0.01% 2166
2019
Q1
$1.05M Buy
59,800
+2,100
+4% +$33.1K ﹤0.01% 2225
2018
Q4
$740K Buy
57,700
+15,100
+35% +$211K ﹤0.01% 2332
2018
Q3
$694K Buy
42,600
+15,000
+54% +$177K ﹤0.01% 2489
2018
Q2
$313K Buy
27,600
+16,600
+151% +$183K ﹤0.01% 2798
2018
Q1
$107K Buy
+11,000
New +$105K ﹤0.01% 2953

Other funds holding FATE